-
1
-
-
70449264503
-
Density, fat, water and solids in freshly isolated tissues
-
Allen, T. H., Krzywicki, H. J. and Roberts, E. (1959). Density, fat, water and solids in freshly isolated tissues. Journal of Applied Physiology 14, 1005-1008
-
(1959)
Journal of Applied Physiology
, vol.14
, pp. 1005-1008
-
-
Allen, T.H.1
Krzywicki, H.J.2
Roberts, E.3
-
2
-
-
0038574979
-
Ion suppression in mass spectrometry
-
Annesely, T. M. (2003). Ion suppression in mass spectrometry. Clinical Chemistry 49, 1041-1044
-
(2003)
Clinical Chemistry
, vol.49
, pp. 1041-1044
-
-
Annesely, T.M.1
-
3
-
-
0034991804
-
Pharmacokinetic investigations in patients from Northern Angola refractory to Melarsoprol treatment
-
Burri, C. and Keiser, J. (2001). Pharmacokinetic investigations in patients from Northern Angola refractory to Melarsoprol treatment. Tropical Medicine International Health 6, 412-420
-
(2001)
Tropical Medicine International Health
, vol.6
, pp. 412-420
-
-
Burri, C.1
Keiser, J.2
-
4
-
-
0027945108
-
Pharmacokinetics of Melarsoprol in uninfected Vervet monkeys
-
Burri, C., Onyango, J. D., Auma, J. E., Burudi, E. M. E. and Brun, R. (1994). Pharmacokinetics of Melarsoprol in uninfected Vervet monkeys. Acta Tropica 58, 35-49
-
(1994)
Acta Tropica
, vol.58
, pp. 35-49
-
-
Burri, C.1
Onyango, J.D.2
Auma, J.E.3
Burudi, E.M.E.4
Brun, R.5
-
5
-
-
33847092850
-
Drugs and drug resistance in African Trypanosomiasis
-
Delespaux, V. and de Koning, H. P. (2007). Drugs and drug resistance in African Trypanosomiasis. Drug Resistance Updates 10, 30-50
-
(2007)
Drug Resistance Updates
, vol.10
, pp. 30-50
-
-
Delespaux, V.1
De Koning, H.P.2
-
6
-
-
21044444153
-
Effectiveness of a 10-day Melarsoprol schedule for the treatment of latestage Human African Trypanosomiasis: Confirmation from a multinational study (IMPAMEL II
-
Doua, F., Asumu, P. N., Cimarro, P. P. and Burri, C. (2005). Effectiveness of a 10-day Melarsoprol schedule for the treatment of latestage Human African Trypanosomiasis: Confirmation from a multinational study (IMPAMEL II). Journal of Infectious Diseases 191, 1922-1931
-
(2005)
Journal of Infectious Diseases
, vol.191
, pp. 1922-1931
-
-
Doua, F.1
Asumu, P.N.2
Cimarro, P.P.3
Burri, C.4
-
7
-
-
34548071206
-
In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids
-
Fridén, M., Gupta, A., Antonsson, M., Bredberg, U. and Hammarlund-Udenaes, M. (2007). In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids. Drug Metabolism and Disposition 35, 1711-1719
-
(2007)
Drug Metabolism and Disposition
, vol.35
, pp. 1711-1719
-
-
Fridén, M.1
Gupta, A.2
Antonsson, M.3
Bredberg, U.4
Hammarlund-Udenaes, M.5
-
8
-
-
73949148635
-
Improved measurement of drug exposure in the brain using drug-specific correction for residual blood
-
Fridén, M., Ljungqvist, H., Middleton, B., Bredberg, U. and Hammarlund-Udenaes, M. (2009). Improved measurement of drug exposure in the brain using drug-specific correction for residual blood. Journal Cerebral Blood Flow and Metabolism 30, 150-161
-
(2009)
Journal Cerebral Blood Flow and Metabolism
, vol.30
, pp. 150-161
-
-
Fridén, M.1
Ljungqvist, H.2
Middleton, B.3
Bredberg, U.4
Hammarlund-Udenaes, M.5
-
9
-
-
0006019247
-
Circulating and tissue hematocrits of normal ananesthetized mic
-
Friedman, J. J. (1959). Circulating and tissue hematocrits of normal ananesthetized mic. American Journal of Physiology 196, 420-422
-
(1959)
American Journal of Physiology
, vol.196
, pp. 420-422
-
-
Friedman, J.J.1
-
10
-
-
12844275226
-
African Trypanosome interactions with an in vitro model of the human bloodbrain barrier
-
Grab, D. J., Nikolskaia, O., Kim, Y. V., Lonsdale-Eccles, J. D., Ito, S., Hara, T., Fukuma, T., Nyarko, E., Kim, K. J., Stins, M. F., Delannoy, M. J., Rodgers, J. and Kim, K. S. (2004). African Trypanosome interactions with an in vitro model of the human bloodbrain barrier. Journal of Parasitology 90, 970-979
-
(2004)
Journal of Parasitology
, vol.90
, pp. 970-979
-
-
Grab, D.J.1
Nikolskaia, O.2
Kim, Y.V.3
Lonsdale-Eccles, J.D.4
Ito, S.5
Hara, T.6
Fukuma, T.7
Nyarko, E.8
Kim, K.J.9
Stins, M.F.10
Delannoy, M.J.11
Rodgers, J.12
Kim, K.S.13
-
11
-
-
79959787951
-
SCYX-7158, an orally-Active benzoxaborole for the treatment of stage 2 human African trypanosomiasis
-
Jacobs, R. T., Nare, B., Wring, S. A., Orr, M. D., Chen, D., Sligar, J. M., Jenks, M. X., Noe, R. A., Bowling, T. S., Mercer, L. T., Rewerts, C., Gaukel, E., Owens, J., Parham, R., Randolph, R., Beaudet, B., Bacchi, C. J., Yarlett, N., Plattner, J. J., Freund, Y., Ding, C., Akama, T., Zhang, Y-K., Brun, R., Kaiser, M., Scandale, I. and Don, R. (2011). SCYX-7158, an orally-Active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Neglected Tropical Diseases 5, 1-11
-
(2011)
PLoS Neglected Tropical Diseases
, vol.5
, pp. 1-11
-
-
Jacobs, R.T.1
Nare, B.2
Wring, S.A.3
Orr, M.D.4
Chen, D.5
Sligar, J.M.6
Jenks, M.X.7
Noe, R.A.8
Bowling, T.S.9
Mercer, L.T.10
Rewerts, C.11
Gaukel, E.12
Owens, J.13
Parham, R.14
Randolph, R.15
Beaudet, B.16
Bacchi, C.J.17
Yarlett, N.18
Plattner, J.J.19
Freund, Y.20
Ding, C.21
Akama, T.22
Zhang, Y.-K.23
Brun, R.24
Kaiser, M.25
Scandale, I.26
Don, R.27
more..
-
12
-
-
0020668981
-
Relapsed parasitemia following chemotherapy of chronic T brucei infections in mice and its relation to cerebral trypanosomes
-
Jennings, F. and Gray, G. (1983). Relapsed parasitemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes. Contributions to Microbiology and Immunology 7, 147-154
-
(1983)
Contributions to Microbiology and Immunology
, vol.7
, pp. 147-154
-
-
Jennings, F.1
Gray, G.2
-
13
-
-
84865966527
-
Safety and efficacy of the 10-Day Melarsoprol schedule for the treatment of second stage rhodesiense sleeping sickness
-
Kuepfer, I., Schmid, C., Allan, M., Edielu, A., Haary, E., Kakembo, A., Kibona, S., Blum, J. and Burri, C. (2012). Safety and efficacy of the 10-Day Melarsoprol schedule for the treatment of second stage rhodesiense sleeping sickness. PLoS Neglected Tropical Diseases 6, e1695
-
(2012)
PLoS Neglected Tropical Diseases
, vol.6
-
-
Kuepfer, I.1
Schmid, C.2
Allan, M.3
Edielu, A.4
Haary, E.5
Kakembo, A.6
Kibona, S.7
Blum, J.8
Burri, C.9
-
14
-
-
0032871338
-
Risk factors for treatment failure after Melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda
-
Legros, D., Evans, S., Maiso, F., Enyaru, J. C. K. and Mbulamberi, D. (1999). Risk factors for treatment failure after Melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda. Transactions of the Royal Society of Tropical Medical Hygiene 93, 439-442
-
(1999)
Transactions of the Royal Society of Tropical Medical Hygiene
, vol.93
, pp. 439-442
-
-
Legros, D.1
Evans, S.2
Maiso, F.3
Enyaru, J.C.K.4
Mbulamberi, D.5
-
15
-
-
33751503409
-
Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from west and central Africa isolated in the periods 1960-1995 and 1999-2004
-
Likefack, A. C. L., Brun, R., Fomena, A. and Truc, P. (2006). Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from west and central Africa isolated in the periods 1960-1995 and 1999-2004. Acta Tropica 100, 11-16
-
(2006)
Acta Tropica
, vol.100
, pp. 11-16
-
-
Likefack, A.C.L.1
Brun, R.2
Fomena, A.3
Truc, P.4
-
16
-
-
38849136513
-
CSF as a surrogate for assessing CNS exposure: An industrial perspective
-
Lin, J. H. (2008). CSF as a surrogate for assessing CNS exposure: An industrial perspective. Current Drug Metabolism 9, 46-59
-
(2008)
Current Drug Metabolism
, vol.9
, pp. 46-59
-
-
Lin, J.H.1
-
17
-
-
28844486224
-
Pharmacodynamics of Caspofungin in a murine model of systemic Candidiasis: Importance of persistence of Caspofungin in tissues to understanding drug activity
-
Louie, A., Deziel, M., Liu, W., Drusano, M. F., Gumbo, T. and Drusano, G. L. (2005). Pharmacodynamics of Caspofungin in a murine model of systemic Candidiasis: Importance of persistence of Caspofungin in tissues to understanding drug activity. Antimicrobial Agents and Chemotherapy 49, 5058-5068
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, pp. 5058-5068
-
-
Louie, A.1
Deziel, M.2
Liu, W.3
Drusano, M.F.4
Gumbo, T.5
Drusano, G.L.6
-
18
-
-
0000062283
-
Influence of protein binding and use of unbound (free) drug concentrations
-
4th Edn (ed. Burton,M. E., Shaw, L. M., Schentag, J. J. and Evans,W. E. Lippincott Williams & Wilkins, Philadelphia, USA
-
MacKichan, J. J. (2005). Influence of protein binding and use of unbound (free) drug concentrations. In: Applied Pharmacokinetics and Pharmacodynamics: Principles of Therapeutic Drug Monitoring, 4th Edn (ed. Burton,M. E., Shaw, L. M., Schentag, J. J. and Evans,W. E.), pp. 82-120. Lippincott Williams & Wilkins, Philadelphia, USA
-
(2005)
Applied Pharmacokinetics and Pharmacodynamics: Principles of Therapeutic Drug Monitoring
, pp. 82-120
-
-
MacKichan, J.J.1
-
19
-
-
4444311359
-
Steady-state brain concentrations of antihistamines in rats
-
Mahar Doan, K. M., Wring, S. A., Shampine, L. J., Jordan, K. H., Bishop, J. P., Kratz, J., Yang, E., Serabjit-Singh, C. J., Adkison, K. K. and Polli, J.W. (2004). Steady-state brain concentrations of antihistamines in rats. Pharmacology 72, 92-98
-
(2004)
Pharmacology
, vol.72
, pp. 92-98
-
-
Mahar Doan, K.M.1
Wring, S.A.2
Shampine, L.J.3
Jordan, K.H.4
Bishop, J.P.5
Kratz, J.6
Yang, E.7
Serabjit-Singh, C.J.8
Adkison, K.K.9
Polli, J.W.10
-
20
-
-
0037122748
-
Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates
-
Mandagere, A. K., Thompson, T. N. and Hwang, K. (2002). Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates. Journal of Medicinal Chemistry 45, 304-311
-
(2002)
Journal of Medicinal Chemistry
, vol.45
, pp. 304-311
-
-
Mandagere, A.K.1
Thompson, T.N.2
Hwang, K.3
-
21
-
-
34548484157
-
Migration of African trypanosomes across the blood-brain barrier
-
Masocha,W., Rottenberg, M. E. and Kristensson, K. (2007). Migration of African trypanosomes across the blood-brain barrier. Physiology and Behavior 92, 110-114
-
(2007)
Physiology and Behavior
, vol.92
, pp. 110-114
-
-
Masocha, W.1
Rottenberg, M.E.2
Kristensson, K.3
-
22
-
-
0034985389
-
Melarsoprol refractory T. B gambiense from Omugo, North-Western Uganda
-
Matovu, E., Enyaru, J. C. K., Legros, D., Schmid, C., Seebeck, T. and Kaminsky, R. (2001). Melarsoprol refractory T. b. gambiense from Omugo, North-Western Uganda. Tropical Medicine and International Health 6, 407-411
-
(2001)
Tropical Medicine and International Health
, vol.6
, pp. 407-411
-
-
Matovu, E.1
Enyaru, J.C.K.2
Legros, D.3
Schmid, C.4
Seebeck, T.5
Kaminsky, R.6
-
23
-
-
0027234946
-
Eflorinithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness
-
Milford, F., Loko, L., Ethier, L., Mpia, B. and Pepin, J. (1993). Eflorinithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness. Transactions of the Royal Society for Tropical Medicine and Hygiene 87, 473-477
-
(1993)
Transactions of the Royal Society for Tropical Medicine and Hygiene
, vol.87
, pp. 473-477
-
-
Milford, F.1
Loko, L.2
Ethier, L.3
Mpia, B.4
Pepin, J.5
-
24
-
-
0942268852
-
Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: Kill curves versus MIC
-
Mueller, M., de la Pena, A. and Derendorf, H. (2004). Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: Kill curves versus MIC. Antimicrobial Agents and Chemotherapy 48, 369-377
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, pp. 369-377
-
-
Mueller, M.1
De La Pena, A.2
Derendorf, H.3
-
25
-
-
77957375428
-
Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system African trypanosomiasis
-
Nare, B., Wring, S., Bacchi, C., Beaudet, B., Bowling, T., Brun, R., Chen, D., Ding, C., Freund, Y., Gaukel, E., Hussain, A., Jarnagin, K., Jenks, M., Kaiser, M., Mercer, L., Mejia, E., Noe, A., Orr, M., Parham, R., Plattner, J., Randolph, R., Rattendi, D., Rewerts, C., Sligar, J., Yarlett, N., Don, R. and Jacobs, R. (2010). Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system African trypanosomiasis. Antimicrobial Agents and Chemotherapy 54, 4379-4388
-
(2010)
Antimicrobial Agents and Chemotherapy
, vol.54
, pp. 4379-4388
-
-
Nare, B.1
Wring, S.2
Bacchi, C.3
Beaudet, B.4
Bowling, T.5
Brun, R.6
Chen, D.7
Ding, C.8
Freund, Y.9
Gaukel, E.10
Hussain, A.11
Jarnagin, K.12
Jenks, M.13
Kaiser, M.14
Mercer, L.15
Mejia, E.16
Noe, A.17
Orr, M.18
Parham, R.19
Plattner, J.20
Randolph, R.21
Rattendi, D.22
Rewerts, C.23
Sligar, J.24
Yarlett, N.25
Don, R.26
Jacobs, R.27
more..
-
26
-
-
0034763005
-
Rational use of in vitro P-glycoprotein assays in drug discovery
-
Polli, J.W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O. and Serabjit-Singh, C. S. (2001). Rational use of in vitro P-glycoprotein assays in drug discovery. Journal of Pharmacology and Experimental Therapeutics 299, 620-628
-
(2001)
Journal of Pharmacology and Experimental Therapeutics
, vol.299
, pp. 620-628
-
-
Polli, J.W.1
Wring, S.A.2
Humphreys, J.E.3
Huang, L.4
Morgan, J.B.5
Webster, L.O.6
Serabjit-Singh, C.S.7
-
27
-
-
38449084743
-
Nifurtomox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping slickness: A randomized trial in Congo
-
Priotto, G., Kasparian, S., Ngouama, D., Ghorashien, S., Arnold, U., Ghabri, S. and Karunakara (2007). Nifurtomox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping slickness: A randomized trial in Congo. CSE Theme Article, CID 45, 1435-1442
-
(2007)
CSE Theme Article, CID
, vol.45
, pp. 1435-1442
-
-
Priotto, G.1
Kasparian, S.2
Ngouama, D.3
Ghorashien, S.4
Arnold, U.5
Ghabri, S.6
Karunakara7
-
28
-
-
41649090595
-
Safety and effectiveness of first line Eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: Cohort study
-
Priotto, G., Pinoges, L., Fursa, I. B., Burke, B., Nicolay, N., Grillet, G., Hewison, C. and Balasegaram, M. (2008). Safety and effectiveness of first line Eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: Cohort study. British Medical Journal 336, 705-708
-
(2008)
British Medical Journal
, vol.336
, pp. 705-708
-
-
Priotto, G.1
Pinoges, L.2
Fursa, I.B.3
Burke, B.4
Nicolay, N.5
Grillet, G.6
Hewison, C.7
Balasegaram, M.8
-
29
-
-
54349101877
-
The blood-brain barrier significantly limits eflornithine entry into the Trypanosoma brucei brucei infected Mouse Brain
-
Sanderson, L., Dogruel, M., Rodgers, J., Bradley, B. and Thomas, S. A. (2008). The blood-brain barrier significantly limits eflornithine entry into the Trypanosoma brucei brucei infected Mouse Brain. Journal of Neurochemistry 107, 1136
-
(2008)
Journal of Neurochemistry
, vol.107
, pp. 1136
-
-
Sanderson, L.1
Dogruel, M.2
Rodgers, J.3
Bradley, B.4
Thomas, S.A.5
-
30
-
-
66749136560
-
Pentamidine movement across the murine bloodbrain and blood-cerebrospinal fluid barriers: Effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistanceassociated protein
-
Sanderson, L., Dogruel, M., Rodgers, J., De Koning, H. P. and Thomas, S. A. (2009). Pentamidine movement across the murine bloodbrain and blood-cerebrospinal fluid barriers: Effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistanceassociated protein. Journal of Pharmacology and Experimental Therapeutics 329, 967-977
-
(2009)
Journal of Pharmacology and Experimental Therapeutics
, vol.329
, pp. 967-977
-
-
Sanderson, L.1
Dogruel, M.2
Rodgers, J.3
De Koning, H.P.4
Thomas, S.A.5
-
31
-
-
4444384506
-
Efficacy of 10-day Melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness
-
Schmid, C., Nkunku, S., Merolle, A., Vounatsou, P. and Burri, C. (2004). Efficacy of 10-day Melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness. Lancet 364, 789-790
-
(2004)
Lancet
, vol.364
, pp. 789-790
-
-
Schmid, C.1
Nkunku, S.2
Merolle, A.3
Vounatsou, P.4
Burri, C.5
-
32
-
-
4744353974
-
Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics
-
Shen, D. D., Artru, A. A. and Adkinson, K. K. (2004). Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics. Advanced Drug Delivery Reviews 56, 1825-1857
-
(2004)
Advanced Drug Delivery Reviews
, vol.56
, pp. 1825-1857
-
-
Shen, D.D.1
Artru, A.A.2
Adkinson, K.K.3
-
33
-
-
35748961582
-
In vitro prediction of brain penetration-A case for free thinking
-
Summerfield, S. G. and Jeffrey, P. (2006). In vitro prediction of brain penetration-A case for free thinking. Expert Opinion 1, 595-607
-
(2006)
Expert Opinion
, vol.1
, pp. 595-607
-
-
Summerfield, S.G.1
Jeffrey, P.2
-
34
-
-
33644756715
-
Improving the in vitro prediction of in vivo central nervous system penetration: Integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain
-
Summerfield, S. G., Stevens, A. J., Cutler, L., del Carmen Osuna, M., Hammond, B., Tang, S., Hersey, A., Spalding, D. J. and Jeffrey, P. (2006). Improving the in vitro prediction of in vivo central nervous system penetration: Integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. Drug Metabolism and Disposition 316, 1282-1290
-
(2006)
Drug Metabolism and Disposition
, vol.316
, pp. 1282-1290
-
-
Summerfield, S.G.1
Stevens, A.J.2
Cutler, L.3
Del Carmen Osuna, M.4
Hammond, B.5
Tang, S.6
Hersey, A.7
Spalding, D.J.8
Jeffrey, P.9
-
35
-
-
4844223855
-
In vitro absorption and secretory quotients: Practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein- mediated efflux on drug candidates
-
Thiel-Demby, V. E., Tippin, T. K., Humphreys, J. E., Serabjit-Singh, C. J. and Polli, J.W. (2004). In vitro absorption and secretory quotients: Practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein-mediated efflux on drug candidates. Journal Pharmaceutical Science 93, 2567-2572
-
(2004)
Journal Pharmaceutical Science
, vol.93
, pp. 2567-2572
-
-
Thiel-Demby, V.E.1
Tippin, T.K.2
Humphreys, J.E.3
Serabjit-Singh, C.J.4
Polli, J.W.5
-
36
-
-
78650682602
-
Fexinidazole-A new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness
-
Torreele, E., Bourdin Trunz, B., Tweats, D., Kaiser, M., Brun, R., Mazué, G., Bray, M. and Pécoul, B. (2010). Fexinidazole-A new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Neglected Tropical Diseases 4, e923
-
(2010)
PLoS Neglected Tropical Diseases
, vol.4
-
-
Torreele, E.1
Bourdin Trunz, B.2
Tweats, D.3
Kaiser, M.4
Brun, R.5
Mazué, G.6
Bray, M.7
Pécoul, B.8
-
37
-
-
0042905800
-
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium
-
Troutman, M. D. and Thakker, D. R. (2003). Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharmaceutical Research 20, 1210-1224
-
(2003)
Pharmaceutical Research
, vol.20
, pp. 1210-1224
-
-
Troutman, M.D.1
Thakker, D.R.2
-
38
-
-
34247532765
-
A direct method for measuring mouse capillary cortical blood volume using multiphoton laser scanning microscopy
-
Vérant, P., Serduc, R., Van Der Sanden, B., Rémy, C. and Vial, J-C. (2007). A direct method for measuring mouse capillary cortical blood volume using multiphoton laser scanning microscopy. Journal of Cerebral Blood Flow and Metabolism 27, 1072-1081
-
(2007)
Journal of Cerebral Blood Flow and Metabolism
, vol.27
, pp. 1072-1081
-
-
Vérant, P.1
Serduc, R.2
Van Der Sanden, B.3
Rémy, C.4
Vial, J.-C.5
-
39
-
-
63849337048
-
Receptor occupancy and brain free fraction
-
Watson, J., Wright, S., Lucas, A., Clarke, K. L., Viggers, J., Cheetham, S., Jeffrey, P., Porter, R. and Read, K. D. (2009). Receptor occupancy and brain free fraction. Drug Metabolism and Disposition 37, 753-760
-
(2009)
Drug Metabolism and Disposition
, vol.37
, pp. 753-760
-
-
Watson, J.1
Wright, S.2
Lucas, A.3
Clarke, K.L.4
Viggers, J.5
Cheetham, S.6
Jeffrey, P.7
Porter, R.8
Read, K.D.9
|